Folate catabolism in pregnant and nonpregnant women with controlled folate intakes
- PMID: 9446844
- DOI: 10.1093/jn/128.2.204
Folate catabolism in pregnant and nonpregnant women with controlled folate intakes
Abstract
Measurement of the urinary folate catabolites, para-aminobenzoylglutamate (pABG) and the more predominant acetylated form, acetamidobenzoylglutamate (apABG), has been used to assess folate requirements in both pregnant and nonpregnant women. Folate catabolite excretion has been reported to be significantly higher in pregnant women (second trimester) compared with nonpregnant controls. The primary goals of this study were to determine if pregnant women in a controlled metabolic study excreted higher quantities of urinary folate catabolites than nonpregnant controls and if catabolite excretion was influenced by folate intake. We evaluated the effect of gestation and folate intake on the urinary excretion of apABG and pABG in pregnant women (n = 12; wk 14-26 gestation) and nonpregnant controls (n = 12) assigned to consume folate levels approximating the current (400 microg/d) and previous (800 microg/d) RDA. Subjects were fed a controlled diet containing 120 microg folate/d and either 330 or 730 microg synthetic folic acid/d. In contrast to previously reported data, no differences in mean folate catabolite excretion were detected between pregnant and nonpregnant subjects. Catabolite excretion (pABG + apABG) decreased significantly relative to initial values in pregnant women consuming 450 microg folate/d (-40 +/- 20%; mean +/- SD) and final mean excretion was significantly lower in the pregnant women consuming 450 microg folate/d (86 +/- 32 nmol/d) compared with 850 microg folate/d (148 +/- 20 nmol/d). Data from this study indicate that second trimester pregnant women do not excrete more folate catabolites than nonpregnant controls and that consumption of 450 vs. 850 microg folate/d results in a significant reduction in the quantity of folate catabolites excreted.
Similar articles
-
Kinetics of folate turnover in pregnant women (second trimester) and nonpregnant controls during folic acid supplementation: stable-isotopic labeling of plasma folate, urinary folate and folate catabolites shows subtle effects of pregnancy on turnover of folate pools.J Nutr. 2001 Jul;131(7):1928-37. doi: 10.1093/jn/131.7.1928. J Nutr. 2001. PMID: 11435509 Clinical Trial.
-
Consumption of the folate breakdown product para-aminobenzoylglutamate contributes minimally to urinary folate catabolite excretion in humans: investigation using [(13)C(5)]para-aminobenzoylglutamate.J Nutr. 2002 Sep;132(9):2613-6. doi: 10.1093/jn/132.9.2613. J Nutr. 2002. PMID: 12221219 Clinical Trial.
-
Folate status response to controlled folate intake in pregnant women.J Nutr. 1997 Dec;127(12):2363-70. doi: 10.1093/jn/127.12.2363. J Nutr. 1997. PMID: 9405587 Clinical Trial.
-
New standard for dietary folate intake in pregnant women.Am J Clin Nutr. 2000 May;71(5 Suppl):1304S-7S. doi: 10.1093/ajcn/71.5.1304s. Am J Clin Nutr. 2000. PMID: 10799406 Review.
-
Folate metabolism and requirements.J Nutr. 1999 Apr;129(4):779-82. doi: 10.1093/jn/129.4.779. J Nutr. 1999. PMID: 10203550 Review.
Cited by
-
Folate pathways mediating the effects of ethanol in tumorigenesis.Chem Biol Interact. 2020 Jun 1;324:109091. doi: 10.1016/j.cbi.2020.109091. Epub 2020 Apr 10. Chem Biol Interact. 2020. PMID: 32283069 Free PMC article. Review.
-
Association between one-carbon metabolism indices and DNA methylation status in maternal and cord blood.Sci Rep. 2018 Nov 15;8(1):16873. doi: 10.1038/s41598-018-35111-1. Sci Rep. 2018. PMID: 30442960 Free PMC article.
-
Biomarkers of Nutrition for Development-Folate Review.J Nutr. 2015 Jul;145(7):1636S-1680S. doi: 10.3945/jn.114.206599. Epub 2015 Jun 3. J Nutr. 2015. PMID: 26451605 Free PMC article. Review.
-
Nutrient intake values for folate during pregnancy and lactation vary widely around the world.Nutrients. 2013 Sep 30;5(10):3920-47. doi: 10.3390/nu5103920. Nutrients. 2013. PMID: 24084052 Free PMC article. Review.
-
Folic acid supplementation during pregnancy for maternal health and pregnancy outcomes.Cochrane Database Syst Rev. 2013 Mar 28;2013(3):CD006896. doi: 10.1002/14651858.CD006896.pub2. Cochrane Database Syst Rev. 2013. PMID: 23543547 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical